116 related articles for article (PubMed ID: 20691161)
21. Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol.
Catani MV; Fezza F; Baldassarri S; Gasperi V; Bertoni A; Pasquariello N; Finazzi-Agrò A; Sinigaglia F; Avigliano L; Maccarrone M
J Mol Med (Berl); 2009 Jan; 87(1):65-74. PubMed ID: 18820887
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes.
Van Dross RT
Mol Carcinog; 2009 Aug; 48(8):724-32. PubMed ID: 19148897
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development.
Galve-Roperh I; Aguado T; Rueda D; Velasco G; Guzmán M
Curr Pharm Des; 2006; 12(18):2319-25. PubMed ID: 16787257
[TBL] [Abstract][Full Text] [Related]
25. Anandamide: an update.
Smita K; Sushil Kumar V; Premendran JS
Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know.
Alger BE
J Physiol; 2012 May; 590(10):2203-12. PubMed ID: 22289914
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines.
Miyato H; Kitayama J; Yamashita H; Souma D; Asakage M; Yamada J; Nagawa H
J Surg Res; 2009 Jul; 155(1):40-7. PubMed ID: 19394652
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the endocannabinoid system in periodontal healing.
Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
[TBL] [Abstract][Full Text] [Related]
29. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
[TBL] [Abstract][Full Text] [Related]
30. Is there a role for endocannabinoids in sperm-oviduct interaction?
Talevi R; Barbato V; De Iorio S; Mollo V; Capriglione T; Ricchiari L; Samo A; Gualtieri R
Reproduction; 2010 Aug; 140(2):247-57. PubMed ID: 20511399
[TBL] [Abstract][Full Text] [Related]
31. The "dark side" of endocannabinoids: a neurotoxic role for anandamide.
Cernak I; Vink R; Natale J; Stoica B; Lea PM; Movsesyan V; Ahmed F; Knoblach SM; Fricke ST; Faden AI
J Cereb Blood Flow Metab; 2004 May; 24(5):564-78. PubMed ID: 15129189
[TBL] [Abstract][Full Text] [Related]
32. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
34. Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes.
Butt C; Alptekin A; Shippenberg T; Oz M
J Neurochem; 2008 May; 105(4):1235-43. PubMed ID: 18194436
[TBL] [Abstract][Full Text] [Related]
35. A common molecular basis for exogenous and endogenous cannabinoid potentiation of glycine receptors.
Xiong W; Wu X; Li F; Cheng K; Rice KC; Lovinger DM; Zhang L
J Neurosci; 2012 Apr; 32(15):5200-8. PubMed ID: 22496565
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoids: synthesis and degradation.
Di Marzo V
Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
[TBL] [Abstract][Full Text] [Related]
37. Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells.
Opitz CA; Rimmerman N; Zhang Y; Mead LE; Yoder MC; Ingram DA; Walker JM; Rehman J
FEBS Lett; 2007 Oct; 581(25):4927-31. PubMed ID: 17904123
[TBL] [Abstract][Full Text] [Related]
38. [The endocannabinoid system and food intake control].
Rodríguez de Fonseca F
Rev Med Univ Navarra; 2004; 48(2):18-23. PubMed ID: 15382609
[TBL] [Abstract][Full Text] [Related]
39. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium.
Chen P; Hu S; Yao J; Moore SA; Spector AA; Fang X
Microvasc Res; 2005 Jan; 69(1-2):28-35. PubMed ID: 15797258
[TBL] [Abstract][Full Text] [Related]
40. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
